Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069432912> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2069432912 endingPage "685" @default.
- W2069432912 startingPage "685" @default.
- W2069432912 abstract "Editorials15 April 1998Transesophageal Echocardiography and Atrial Fibrillation: Added Value or Expensive Toy?Warren J. Manning, MD and Pamela S. Douglas, MDWarren J. Manning, MDBeth Israel Deaconess Medical Center; Boston, MA 02215Search for more papers by this author and Pamela S. Douglas, MDBeth Israel Deaconess Medical Center; Boston, MA 02215Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-8-199804150-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Atrial fibrillation, the most common type of sustained arrhythmia, is associated with considerable morbidity and mortality from stroke and systemic thromboembolism. Several large, randomized, multicenter studies have documented that systemic warfarin anticoagulation reduces thromboembolic complications associated with atrial fibrillation by two thirds [1, 2], presumably because of warfarin's efficacy in inhibiting thrombus formation within the stagnant left atrial appendage. Long-term warfarin therapy, however, is associated with the cost and inconvenience of monitoring and high morbidity and mortality. These effects are especially prevalent among elderly persons, a population at high risk for thromboembolic complications of atrial fibrillation [3]. The identification of ...References1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized, controlled trials. Atrial Fibrillation Investigators. Arch Intern Med. 1994; 154:1449-57. Google Scholar2. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993; 342:1255-62. Google Scholar3. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. Stroke Prevention in Atrial Fibrillation Investigators. Journal of Stroke and Cerebrovascular Disorders. 1995; 5:147-57. Google Scholar4. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med. 1995; 123:817-22. Google Scholar5. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol. 1995; 25:1354-61. Google Scholar6. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med. 1998; 128:639-47. Google Scholar7. Stollberger C, Chnupa P, Kronik G, Brainin M, Finsterer J, Schneider B, et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Ann Intern Med. 1998; 128:630-8. Google Scholar8. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet. 1996; 348:633-8. Google Scholar9. Manning WJ, Silverman DI, Keighley KS, Waksmonski CA, Oettgen P, Douglas PS. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med. 1995; 155:2193-7. Google Scholar10. Leung DY, Davidson PM, Cranney GB, Walsh WF. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol. 1997; 79:626-9. Google Scholar11. Goldman MJ. The management of chronic atrial fibrillation: indications for and method of conversion to sinus rhythm. Prog Cardiovasc Dis. 1960; 465-79. Google Scholar12. Collins LJ, Silverman DI, Douglas PS, Manning WJ. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation. 1995; 92:160-3. Google Scholar13. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med. 1996; 334:1216-21. Google Scholar14. Cox JL, Boineau JP, Schuessler RB, Ferguson TB Jr, Cain ME, Lindsay BD, et al. Successful surgical treatment of atrial fibrillation. Review and clinical update. JAMA. 1991; 266:1976-80. Google Scholar15. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996; 61:755-9. Google Scholar16. Daniel WG, Nellessen U, Schroder E, Nonnast-Daniel B, Bednarski P, Nikutta P, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol. 1988; 11:1204-11. Google Scholar17. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994; 23:961-9. Google Scholar18. Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 1991; 18:398-404. Google Scholar19. Seto TB, Taira DA, Tsevat J, Manning WJ. Cost-effectiveness of transesophageal echocardiography-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation. J Am Coll Cardiol. 1997; 29:122-30. Google Scholar20. Tsai LM, Chen JH, Lin LJ, Teng JK. Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol. 1997; 80:897-900. Google Scholar Author, Article, and Disclosure InformationAffiliations: Beth Israel Deaconess Medical Center; Boston, MA 02215Corresponding Author: Pamela S. Douglas, MD, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215.Current Author Addresses: Drs. Manning and Douglas: Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic reviewInteractions Between Cardiovascular and Cerebrovascular DiseaseTransnasal transesophageal echocardiography in the detection of left atrial thrombusChapter 51 The interactions between cardiovascular and cerebrovascular diseaseRole of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillationAnticoagulation Before and After Percutaneous Balloon Valvuloplasty for Mitral StenosisUse of Oral Anticoagulants in Older PatientsAtrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke PreventionRobert G. Hart, MD and Jonathan L. Halperin, MDEpidemiology and significance of atrial fibrillationMedical advice editorials: Transferring medical science into clinical practiceAortic Plaque in Atrial FibrillationAntithrombotic Therapy in Nonrheumatic/Nonvalvular Atrial Fibrillation 15 April 1998Volume 128, Issue 8Page: 685-687KeywordsAspirinAtrial fibrillationEchocardiographyMedical risk factorsMorbidityMortalityResearch designStrokeThromboembolismThrombosis Issue Published: 15 April 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ..." @default.
- W2069432912 created "2016-06-24" @default.
- W2069432912 creator A5002927848 @default.
- W2069432912 date "1998-04-15" @default.
- W2069432912 modified "2023-09-25" @default.
- W2069432912 title "Transesophageal Echocardiography and Atrial Fibrillation: Added Value or Expensive Toy?" @default.
- W2069432912 cites W1978894460 @default.
- W2069432912 cites W2008858901 @default.
- W2069432912 cites W2014679230 @default.
- W2069432912 cites W2040648330 @default.
- W2069432912 cites W2053482681 @default.
- W2069432912 cites W2074782779 @default.
- W2069432912 cites W2076660738 @default.
- W2069432912 cites W2077912211 @default.
- W2069432912 cites W2091787186 @default.
- W2069432912 cites W2097475771 @default.
- W2069432912 cites W2112255573 @default.
- W2069432912 cites W2126596713 @default.
- W2069432912 cites W2169859159 @default.
- W2069432912 cites W44202489 @default.
- W2069432912 cites W2075575418 @default.
- W2069432912 cites W2292956551 @default.
- W2069432912 cites W2315110984 @default.
- W2069432912 doi "https://doi.org/10.7326/0003-4819-128-8-199804150-00013" @default.
- W2069432912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9537943" @default.
- W2069432912 hasPublicationYear "1998" @default.
- W2069432912 type Work @default.
- W2069432912 sameAs 2069432912 @default.
- W2069432912 citedByCount "18" @default.
- W2069432912 countsByYear W20694329122012 @default.
- W2069432912 countsByYear W20694329122013 @default.
- W2069432912 countsByYear W20694329122016 @default.
- W2069432912 crossrefType "journal-article" @default.
- W2069432912 hasAuthorship W2069432912A5002927848 @default.
- W2069432912 hasConcept C126322002 @default.
- W2069432912 hasConcept C127413603 @default.
- W2069432912 hasConcept C164705383 @default.
- W2069432912 hasConcept C168563851 @default.
- W2069432912 hasConcept C2776301958 @default.
- W2069432912 hasConcept C2777015399 @default.
- W2069432912 hasConcept C2777628954 @default.
- W2069432912 hasConcept C2779161974 @default.
- W2069432912 hasConcept C2780645631 @default.
- W2069432912 hasConcept C2781362458 @default.
- W2069432912 hasConcept C2908647359 @default.
- W2069432912 hasConcept C71924100 @default.
- W2069432912 hasConcept C78519656 @default.
- W2069432912 hasConcept C99454951 @default.
- W2069432912 hasConceptScore W2069432912C126322002 @default.
- W2069432912 hasConceptScore W2069432912C127413603 @default.
- W2069432912 hasConceptScore W2069432912C164705383 @default.
- W2069432912 hasConceptScore W2069432912C168563851 @default.
- W2069432912 hasConceptScore W2069432912C2776301958 @default.
- W2069432912 hasConceptScore W2069432912C2777015399 @default.
- W2069432912 hasConceptScore W2069432912C2777628954 @default.
- W2069432912 hasConceptScore W2069432912C2779161974 @default.
- W2069432912 hasConceptScore W2069432912C2780645631 @default.
- W2069432912 hasConceptScore W2069432912C2781362458 @default.
- W2069432912 hasConceptScore W2069432912C2908647359 @default.
- W2069432912 hasConceptScore W2069432912C71924100 @default.
- W2069432912 hasConceptScore W2069432912C78519656 @default.
- W2069432912 hasConceptScore W2069432912C99454951 @default.
- W2069432912 hasIssue "8" @default.
- W2069432912 hasLocation W20694329121 @default.
- W2069432912 hasLocation W20694329122 @default.
- W2069432912 hasOpenAccess W2069432912 @default.
- W2069432912 hasPrimaryLocation W20694329121 @default.
- W2069432912 hasRelatedWork W2037180721 @default.
- W2069432912 hasRelatedWork W2038817894 @default.
- W2069432912 hasRelatedWork W2043890723 @default.
- W2069432912 hasRelatedWork W2081192620 @default.
- W2069432912 hasRelatedWork W2114891295 @default.
- W2069432912 hasRelatedWork W2134968660 @default.
- W2069432912 hasRelatedWork W2157711058 @default.
- W2069432912 hasRelatedWork W2325909460 @default.
- W2069432912 hasRelatedWork W2372447844 @default.
- W2069432912 hasRelatedWork W2418235060 @default.
- W2069432912 hasVolume "128" @default.
- W2069432912 isParatext "false" @default.
- W2069432912 isRetracted "false" @default.
- W2069432912 magId "2069432912" @default.
- W2069432912 workType "article" @default.